✓Strengths
- Comfortable interest cover: operating profit covers interest about 7 times.
- Return on equity is healthy at 18%.
- Return on capital employed is healthy at 23.3%.
- Net profit margin is 8.3%.
- Has paid a dividend in each of the last 3 years on record.
!Watch-points
- Higher leverage: debt-to-equity of 1.07 is above 1.
- Sales growth has been slow over five years (about 3% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.05
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the market-value term.
Piotroski F-ScoreModerate
4 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Book Value₩ 5,838.70
ROCE23.32%
ROE18.04%
Debt to Equity1.07
Current Ratio1.35
EPS₩ 1,053.00
PAT Margin8.30%
ICR6.95
Compounded Sales Growth
10 Years
—
5 Years
2.98%
3 Years
—
TTM
—
Compounded Profit Growth
10 Years
—
5 Years
10.69%
3 Years
—
TTM
—
Stock Price CAGR
10 Years
—
5 Years
—
3 Years
—
1 Year
—
Return on Equity
10 Years
—
5 Years
—
3 Years
—
Last Year
18.04%